Rockwell Medical (RMTI) Earnings Analysis

Rockwell Medical (RMTI) next reports earnings on 2026-08-13, consensus EPS -0.235 USD. Last quarter (2026-05-07) it missed with EPS -0.4 USD vs -0.1 USD est (-300%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -4.33.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does RMTI next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.235 USD
Revenue estimate0.02B

RMTI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.4 USD-0.1 USD-300%Miss
2026-03-26-0.1 USD0.4 USD-125%Miss
2025-08-14-0.05 USD-0.05 USD0%Beat
2025-05-12-0.04 USD-0.3 USD+86.7%Beat
2025-03-20-0.02 USD0.02 USD-200%Miss
2024-11-110.5 USD0.1 USD+400%Beat
2024-08-120.01 USD-0.3 USD+103.3%Beat

Beat rate: 4/7 (57%) over reported quarters with consensus data.

RMTI valuation and analyst view

Trailing P/E-4.33
Trailing EPS-1.37094 USD
Price / book0.71
Dividend yield0.00%
Market cap0.03B
Analyst consensusBuy (10 buy / 2 hold / 4 sell)
Avg price target11 USD

Related research pages

Frequently asked questions

When is Rockwell Medical (RMTI)'s next earnings date?

Rockwell Medical is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.235 USD and revenue estimate of 0.02B.

Did RMTI beat earnings last quarter?

In its 2026-05-07 report, RMTI posted EPS of -0.4 USD versus a -0.1 USD estimate — a miss of 300%.

What is RMTI's earnings track record?

Over the last 7 reported quarters with consensus data, RMTI beat estimates 4 times (57%).

What is RMTI's current P/E ratio and EPS?

RMTI trades at a trailing P/E of -4.33 on trailing EPS of -1.3709368491284506 USD.

What do analysts rate RMTI?

Analyst consensus is "Buy" across 16 ratings (0 strong buy, 10 buy, 2 hold, 4 sell, 0 strong sell). Average 12-month price target: 11 USD.